Literature DB >> 8542736

Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?

J Larsson1, J Apelqvist, C D Agardh, A Stenström.   

Abstract

The purpose of this retrospective study was to evaluate the changes in diabetes-related lower extremity amputations following the implementation of a multidisciplinary programme for prevention and treatment of diabetic foot ulcers in a 0.2 million population with a 2.4% prevalence of diabetes. All diabetes-related primary amputations from toe to hip from 1 January 1982 to 31 December 1993 were included. In 294 diabetic patients, 387 primary major (above the ankle) or minor (through or below the ankle) amputations were performed, constituting 48% of all lower extremity amputations. The annual number of amputations at all levels decreased from 38 to 21, equalling a decrease of incidence from 19.1 to 9.4/100,000 inhabitants (p = 0.001). The incidence of major amputations decreased by 78% from 16/1 to 3.6/100,000 inhabitants (p < 0.001). The absolute number of amputations with a final level below the ankle showed no increase, but their proportion increased from 28 to 53% (p < 0.001) and the reamputation rate decreased from 36 to 22% (p < 0.05) between the first and last 3-year period. Thus, a substantial long-term decrease in the incidence of major amputations was seen as well as a decrease in the total incidence of amputations in diabetic patients. Seventy-one per cent of the amputations were precipitated by a foot ulcer. These findings indicate that a multidisciplinary approach plays an important role to reduce and maintain a low incidence of major amputations in diabetic patients.

Entities:  

Mesh:

Year:  1995        PMID: 8542736     DOI: 10.1111/j.1464-5491.1995.tb02078.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  36 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 2.  Diagnostics and treatment of the diabetic foot.

Authors:  Jan Apelqvist
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

Review 3.  A review of the surgical management of heel pressure ulcers in the 21st century.

Authors:  David C Bosanquet; Ann M Wright; Richard D White; Ian M Williams
Journal:  Int Wound J       Date:  2015-02-16       Impact factor: 3.315

Review 4.  Amputation as a marker of the quality of foot care in diabetes.

Authors:  W J Jeffcoate; W H van Houtum
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

Review 5.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

Review 6.  Diabetic foot wounds: the value of negative pressure wound therapy with instillation.

Authors:  Luca Dalla Paola
Journal:  Int Wound J       Date:  2013-12       Impact factor: 3.315

7.  Costs of deep foot infections in patients with diabetes mellitus.

Authors:  G R Tennvall; J Apelqvist; M Eneroth
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

8.  Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Bruce A Perler; Julie A Freischlag; James H Black; Christopher J Abularrage
Journal:  J Vasc Surg       Date:  2014-06-14       Impact factor: 4.268

9.  Preliminary Experience with Conservative Sharp Wound Debridement by Nurses in the Outpatient Management of Diabetic Foot Ulcers: Safety, Efficacy, and Economic Analysis.

Authors:  Ross A Schumer; Brian L Guetschow; Marissa V Ripoli; Phinit Phisitkul; Sue E Gardner; John E Femino
Journal:  Iowa Orthop J       Date:  2020

Review 10.  Challenges for management of the diabetic foot in Africa: doing more with less.

Authors:  Zulfiqarali G Abbas; Lennox K Archibald
Journal:  Int Wound J       Date:  2007-10-24       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.